Table 1.
α2δ subunit isoforms and mouse and human disease phenotypes
Mouse | Human | |||
---|---|---|---|---|
| ||||
Isoform | Mouse models | Phenotype | Potential cause | Disease |
α2δ-1 | knock-in1 (GBP insensitive) | no known CNS phenotype1 | aberrations of CACNA2D15 | epilepsy and intellectual disability5 |
knockout2 | reduced pain sensitivity3, no known CNS phenotype1 | |||
α2δ-1 over-expressing4 | hyperalgesia, tactile allodynia4 | |||
| ||||
α2δ-2 | spontaneous loss-of-function mutations6,7,8,9 (ducky, ducky2j, entla), knockout10 | ataxia, epilepsy and paroxysmal dyskinesia6,7,8,9,10 | homozygous mutations (point11 and frameshift12) | epileptic encephalopathy11,12 |
genomic deletion of CACNA2D213,14 | potential tumor suppressor gene13,14 | |||
single-nucleotide polymorphisms (SNPs)15 | candidate gene in childhood absence epilepsy15 | |||
| ||||
α2δ-3 | knockout16 | deficits in pain16 and auditory/acoustic startle processing17 | SNPs16 | reduced sensitivity to acute noxious heat and chronic back pain16 |
splice site mutation in CACNA2D318 | autism spectrum disorders18 | |||
| ||||
α2δ-4 | spontaneous mutation (premature stop)19 | structural and functional abnormalities in ribbon synapses, loss of rods19 | mutation (premature stop) of CACNA2D420 | slowly progressive cone dystrophy and night blindness20 |
partial deletion of CACNA2D421 | psychiatric disorders21 |